MedTrace Logo

B. Lactis HN019 for Functional Constipation

NCT01463293 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2014-07-24

Study results available
· View outcomes & findings →

Summary

This study will investigate the effects of 4-week probiotic supplementation on whole gut transit time and gastrointestinal symptoms in adults with functional constipation.

Conditions

Interventions

DIETARY_SUPPLEMENT

B. lactis HN019

Capsule containing 10 billion cfu B. lactis HN019 once a day

DIETARY_SUPPLEMENT

B. lactis HN019

Capsule containing 1 billion cfu B. lactis HN019 once a day

DIETARY_SUPPLEMENT

Placebo

Capsule containing no probiotic once a day

Sponsors & Collaborators

  • DuPont Nutrition and Health

    collaborator INDUSTRY

  • Fonterra Research Centre

    lead INDUSTRY

Principal Investigators

  • Robert Hardi, MD · Capital Digestive Care, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463293 on ClinicalTrials.gov